Type 2 & other diabetes

Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study

DiabetologiaPublished Proteomic analysis of a cohort study with Mendelian randomisation

Authors' conclusion

Identified proteins may represent viable intervention or pharmacological targets to prevent, reverse or slow type 2 diabetes progression, and further research is needed to pursue these targets.

Study context

Population
ARIC cohort participants; plasma levels of 4870 proteins and genetic risk scores (GRS) of T2D phenotypes (beta cell function, insulin resistance, lipodystrophy, BMI/blood lipid abnormalities, composite)
Participants
7,241 vs 1,674
Exposure
White vs Black
  • Whiten = 7,241
  • Blackn = 1,674
Outcome
Proteins and pathways through which T2D risk variants may influence pathophysiology (protein–GRS associations)
Methodological detailsdiscovery and replication samples, Bonferroni correction, two-sample Mendelian randomisation
  • Discovery and replication samples
  • Bonferroni correction
  • Two-sample Mendelian randomisation

Main finding

As reported in the abstract

Protein–GRS associations
Plasma proteins identified in White participants after Bonferroni correction
22
Protein–GRS associations replicated in Black participants
10
Directionally consistent in Black participants
all but one

Observational data: associations, not effects.

Further findings

Proteins associated with T2D

Associated with prevalent T2D
18 of the 22 proteins
Associated with incident T2D
10 proteins
  • Secondary analysis

Two-sample Mendelian randomisation: T2D risk

Complement C2, inverse variance weighted estimate (may be causally related to greater T2D risk): OR per SD
1.65; p=7.0 × 10-3
Neuropilin-2, inversely associated: OR per SD
0.44; p=8.0 × 10-3

Original publication

Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia. Published 4 October 2022. doi:10.1007/s00125-022-05801-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.